Neonatal paroxetine withdrawal syndrome

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 84, Issue 2, 2001, Pages

  Stiskal, J A ^b   Kulin, N ^a   Koren, G ^a   Ho, T ^a   Ito, S ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

Necrotising enterocolitis; Neonates; Paroxetine; Serotonin reuptake inhibitors; Withdrawal

Indexed keywords

PAROXETINE;

ADAPTATION; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HUMAN; MALE; NECROTIZING ENTEROCOLITIS; NERVOUSNESS; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

EID: 0035082099     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.84.2.f134     Document Type: Article

References (10)

1. Fluoxetine hydrochloride (Prozac) toxicity in a neonate
2. Birth outcomes in pregnant women taking fluoxetine
3. A comparison of the post-marketing safety of the four selective serotonin reuptake inhibitors including the investigation of symptoms occurring on withdrawal
4. Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers
5. Paroxetine in the treatment of panic disorder. A randomized, doubleblind, placebo-controlled study
6. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: A literature review
7. The central role of PAF in necrotizing enterocolitis development
8. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors
9. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study
10. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence